At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our
Overview In this role you will design, deploy, and govern a global, scalable commercial capability framework across regions. You’ll collaborate with regional leaders and BUs to align training priorities and drive capability development. You’ll establish governance, measure
Overview At Sephora, beauty is about feeling seen, valued, and empowered, individually and collectively. It is connecting deeply with others, celebrating diversity and inclusivity, unlocking your potential and making a difference every day. Together, we belong
RateHawk is part of Emerging Travel Group— a pioneering travel-tech company also known for its two other brands, ZenHotels and Roundtrip, spanning over 220 markets worldwide. Our mission is to create, distribute, and operate the most
Overview At Sephora, beauty is about feeling seen, valued, and empowered, individually and collectively. It is connecting deeply with others, celebrating diversity and inclusivity, unlocking your potential and making a difference every day. Together, we belong
At Sephora, beauty is about feeling seen, valued, and empowered, individually and collectively. It is connecting deeply with others, celebrating diversity and inclusivity, unlocking your potential and making a difference every day. Together, we belong to
ARE YOU LOOKING FOR YOUR NEXT EXCITING CHALLENGE If the answer is yes, then Future Electronics wants to hear from you! We are currently looking for an experienced Business Development Manager with Memory experience to join our
Colquímica Adhesives is a global leader in hot‑melt adhesives , with operations across Portugal, Poland, and the United States. We develop innovative adhesive solutions that touch millions of lives every day. We’re increasing our Sales Team
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our